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The molecular mechanisms underlying the aging process are
still unclear, but the clonal accumulation of mitochondrial
deletion mutants is one of the prime candidates. An
important question for the mitochondrial theory of aging
is to discover how defective organelles might be selected
at the expense of wild-type mitochondria. We propose
that mitochondrial fission and fusion events are of critical
importance for resolving this apparent contradiction. We
show that the occurrence of fusions removes the problems
associated with the idea that smaller DNA molecules
accumulate because they replicate in a shorter time –
the 
 
survival of the tiny
 
 (SOT) hypothesis. Furthermore,
stochastic simulations of mitochondrial replication,
mutation and degradation show that two important
experimental findings, namely the overall low mosaic
pattern of oxidative phosphorylation (OXPHOS) impaired
cells in old organisms and the distribution of deletion sizes,
can be reproduced and explained by this hypothesis.
Finally, we make predictions that can be tested experimen-
tally to further verify our explanation for the age-related
accumulation of mitochondrial deletion mutants.
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The mitochondrial theory of aging sees the accumulation of
defective mitochondria as the central mechanism responsible
for the aging process. These cellular organelles originated early
in evolution from purple bacteria (Schwartz & Dayhoff, 1978)
and serve as endosymbionts in most modern eukaryotes. As
a remnant from this time they still contain their own genetic
material in the form of circular DNA (mtDNA). During evolution
most genes needed by the mitochondrium have been trans-




. 16.5 kbp in




., 1981). Mitochondria are involved in important processes like
calcium storage, apoptosis and energy production via oxidative
phosphorylation (OXPHOS). Their role as the main energy source
for the cell together with certain properties of the mtDNA is crucial
for their possible involvement in the aging process. Harman (1972)
was the first to propose that reactive oxygen species, which arise
as a bye-product of electron transport during OXPHOS might
damage the mitochondrial DNA and thus impair the energy
supply of the cell. Since all the genes necessary for growth and
replication of the mitochondria are located within the nucleus,
defective organelles could still propagate. Damage to the
mtDNA would effectively turn the symbiont into a parasite. This









., 1989) and leads to the view that defective
mitochondria accumulate with age in cells and tissues, contrib-
uting to the gradual functional decline that characterizes aging.
Experimental support for this idea came from studies that













., 1991). Deletion mutations
accumulate preferentially in postmitotic tissues like heart, brain


















2001). Early studies were performed on tissue homogenates
and although they found an age related increase of mutations,
they concluded that the fraction of defective mtDNAs is well









However, it turned out that the underlying assumption that
mitochondrial damage is distributed homogeneously within
a tissue is wrong. The combination of PCR amplification of
extended sequences together with single cell studies revealed
that muscle tissue displays a mosaic pattern of mitochondrial
damage. While even in old individuals most cells harbour little
or no damaged mitochondria, there are a few cells that contain













., 2004). These studies
demonstrated that in affected cells the mitochondrial popula-
tion was apparently taken over by a single mutant, which was
different for different cells. This suggests that the cellular
accumulation of defective mitochondria proceeds via clonal
expansion of a single originating mutant. Finally, single cell
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respiratory function that had been observed in several species





., 1997) colocalizes with the occurrence of mito-
chondrial deletions. Two enzymatic abnormalities that occur in










), a phenotype known as red ragged fibres.
But how might a single mutant mitochondrium out-compete
the population of wild type (wt) mitochondria? Initially, it was
suggested that the reduced genome size of the deletion mutant









., 1999). A mutant that has lost 8kbp is only
half the size of the wild type and might therefore replicate in
half the time. This idea has fallen into disfavour because even
though the mutant might have a replication advantage it should
also suffer from a severe lack of ATP and a reduced proton
gradient, both of which are important for fast mitochondrial
growth. But most important for the dismissal of the faster rep-
lication idea is the fact that the time required for the replication
of the mtDNA is only 1–2 h (Davis & Clayton, 1996). In contrast,










Consequently, it has been argued that it is very difficult to
imagine how mtDNA replication could be the rate-limiting step





A further possibility that has been suggested is that deletion
mutants have no selection advantage at all, but accumulate by




., 2001). However, this scenario describes only a single
specific case from a continuum of possibilities (negative to
positive selection advantage). If the selection difference between
mutant and wild-type deviates only slightly from zero the
assumptions and predictions of this model no longer apply.
And, considering the multiple consequences of a DNA deletion
(smaller size of mtDNA, production of no or faulty proteins), it
is difficult to see how this could result in a truly selection-neutral
mutation. Other explanations have therefore tried to identify
a selection advantage for mitochondrial mutants (since a dis-





 (SOS) hypothesis proposed by de Grey (1997)
realizes that the fate of a mitochondrial mutant not only depends
on its growth rate, but also on its rate of degradation. A mutant
can gain a selection advantage either through an increased
replication rate or through a decreased rate of degradation. The
idea of the SOS hypothesis is that mitochondria are selected
for degradation by lysosomes depending on their amount of
membrane damage. The more damage, the faster the degrada-
tion rate would be. de Grey argues that mutant mitochondria
have an impaired respiration chain and generate less of the
reactive perhydroxyl radical, which is responsible for most of
the membrane damage. Computer simulations show that
such a mechanism can indeed provide the required selection
advantage (Kowald & Kirkwood, 1999; Kowald & Kirkwood,
2000). Mitochondrial mutants with impaired respiration also
suffer from a chronic ATP shortage and the SOS hypothesis is
an elegant idea to explain how mutants can have a selection
advantage under those conditions.
However, the above arguments depend heavily on the idea
that mitochondria are individual entities, competing with each
other inside the cell. The existence of mitochondrial fusions is
therefore of crucial importance for this assumption. Mitochondria
form dynamic networks, ranging from long tubular forms to
single spherical organelles. Microscopic techniques indicate that
these changes in number and morphology are due to frequent
mitochondrial fission and fusion events (Bereiter-Hahn & Vöth,
1994). The molecular mechanism has been studied during the
last years and several essential proteins have been identified


























., 2004) while our own work demonstrates




., 2005). It is clear that mitochondria of many tissue types
can and do undergo fusion under certain conditions. Whether
mitochondrial fusions occur in skeletal muscle cells under
physiological conditions (which is particularly relevant for
theories of aging) is currently unclear. However, given the large
number of cell types where mitochondrial fusion has been
observed, the aim of this article is to use computer simulation
to study the possible consequences of frequent mitochondrial
fusions for the accumulation of defective mtDNAs.
If fusion does occur, all the mitochondria of a cell will
effectively form one large compartment with constant mixing
of mtDNA as well as matrix and membrane components. Under
these conditions, mtDNA deletions no longer lead to energy and
proton gradient deficiencies within the cell since there is a
common pool. Most importantly, however, the competing entities
are no longer mitochondria, but individual mtDNA molecules.
For the outcome of this competition only the mtDNA replication
times are important, while the apparent mitochondrial growth
rate (which is much longer) is irrelevant. In the following we
therefore describe a model for the accumulation of defective
mitochondria based on the idea that deletion mutants replicate
faster than wild-type (
 






The description and implementation of the model are described




Figure 3 displays the results for simulations using a mutation


















. Part A of the figure is effectively a
contour plot showing the accumulation of mtDNA mutants over
time. The solid line, for instance, indicates the fraction of cells
that contain at least one defective mitochondrial genome (> 0%
mutants) at a given time. Under the mutation rate used in these
simulations, all cells contained one or more mutants after
400 days. Since each simulation run computes the fate of the








mtDNA population of a single cell over time, the ‘fraction of cells’
is identical to the fraction of simulation runs performed. The
other contour lines represent higher levels of defective mtDNAs.
The point marked by the arrow shows that after approx. 200
days, 60% of the cells had a mtDNA population consisting of
at least 20% defective genomes.
The other parameters used for this simulation are summarized
in Table 1 and are as follows. No boost factor has been used
(bF = 1), i.e. defective mtDNA did not increase oxidative stress.
Parameters ‘k’ and ‘c’, necessary for the calculation of the
replication rate, were set to 5000 and 1000, respectively. Together
with the 10 day half-life of mitochondrial DNA, this resulted in
a mtDNA population size of approx. 5500 (data not shown).
This is in good agreement with studies of skeletal and heart
muscle that find values between 3000 and 7000 mtDNA





The diagram shown in Fig. 3(A) summarizes the total number
of defective genomes that accumulate with time, but does not
differentiate among different deletion sizes. For this purpose the
histogram of deletion sizes at the end of the simulation (day
1127) is shown in Fig. 3(B). The histogram has been calculated
from the mitochondrial deletion mutants that were present at
the end of the 1000 simulation runs. The distribution is skewed
with a maximum at around 8 kbp. Interestingly, deletions below
4 kbp are very rare, as observed experimentally (Fig. 1).
Why are there no small deletions, although one of the
assumptions underlying the mutation process is that small dele-
tions occur more often than large ones? A histogram of deletion
sizes can be calculated for every time point of the simulation,
and the results are very instructive. Figure 4 shows the deletion
size distribution for four different, equally spaced, time points.
As can be seen, early on (see day 281) many small deletions
Fig. 1 Distribution of mitochondrial deletion sizes calculated from Cao et al. 
(2001). The authors determined the exact size of 30 mitochondrial deletion 
mutants in 38 months old rats. Mitochondrial deletion mutants in respiration 
deficient muscle fibres were amplified by PCR and sequenced, revealing 
deletion sizes from 4.4 kbp to 9.7 kbp. The histogram shows a conspicuous 
absence of small deletions below 4 kbp. Very large deletions are also rare.
Fig. 2 (A) Overview of the mutations allowed by 
the model. Different mutants are labelled by 
numbers and the larger the number, the larger the 
deletion that this mutant carries. Arrows indicate 
possible mutations, showing that small (M0→M1) 
or large (M0→M4) pieces of DNA can be lost in a 
single mutation event. Mutants can suffer further 
mutations leading to even smaller mutants 
(M1→M4 but not M1→M0). (B) Schematic drawing 
of the rat mtDNA showing OH, the origin of the 
heavy strand synthesis and OL the origin of the light 
strand synthesis. The locations of the origins define 
the minor and major arc with the replication of the 
strands proceeding in the direction indicated by the 
arrows.
Table 1 Parameters and standard values used for the simulations
 
Name Value Description
baseRate 6 * 10
−7 day−1 kbp−1 Mutation rate per day and kbp. Order of magnitude is in accordance with (Shenkar et al., 1996).
bF 1 Factor by which the mutation rate is increased if 100% of the mitochondrial population are deletion mutants.
K 5000 If the number of mitochondria is equal to ‘k’, the synthesis rate of new organelles is half maximal. This is related to the 
number of mtDNAs per cell which ranges from 700 in sperm (Diez-Sanchez et al., 2002), 7000 in heart muscle (Miller 
et al., 2003) to 25 000 in liver (Berdannier & Everts, 2001).
C 1000 Maximum number of mitochondria that can be synthesized per day.
degRate ln(2)/10 day−1 Degradation rate for all mtDNAs. Corresponding to a half-life of 10 days (Huemer et al., 1971; Menzies & Gold, 1971; 
Korr et al., 1998).








down to 0.5 kbp are present. But as time progresses, the shape
of the distribution changes: small deletions disappear and larger
deletions emerge. It appears that the assumption included
in the simulation of the mutation process, that mutants can























 gave a deletion size distribution that closely resembles
experimental observations. However, it was much too high since
it resulted in all cells having at least 60% defective mitochon-
drial genomes around day 600 (Fig. 3A). This is incompatible
with experimental findings that, even in old individuals, tissues
show a mosaic pattern of cells with and without defective
mtDNA.
In a next set of simulations the mutation rate was therefore


















, while all other parameters
were kept constant. Now defective genomes accumulate
much slower and after 1100 days only approx. 50% of all cells
harbour defective genomes while the remainder contain only
wild type mtDNA (Fig. 5A). This is in agreement with the observed
mosaic pattern.
However, now the distribution of deletion sizes has changed
considerably and contains a large fraction of small and very small
deletions (Fig. 5B), no longer corresponding to the experimental
distribution. What is the reason for this discrepancy? In the
earlier simulations, mutants with small deletions disappeared
because they suffered further deletion mutations. These second
generation mutants had a replication advantage because of
their smaller size and could thus replace the first generation
mutants. But by reducing the mutation rate 20 fold, the pro-
duction of second generation mutants is not frequent enough
to drive this process. The result is the persistence of many
mutants with small deletions until the end of the simulation.
Fig. 4 Distribution of mitochondrial deletion sizes 
at various time points during the life of a rat. The 
simulation details are identical to Fig. 3, but this 
time the deletion size distribution is shown for four 
equally spaced time points. Early in life (day 281) 
the distribution contains a large fraction of small 
deletions down to 0.5 kbp. As time progresses, 
these small deletions disappear until finally (day 
1127) the distribution shown in Fig. 3B has been 
reached.
Fig. 3 Simulation results for a high mitochondrial mutation rate 
(6 * 10
−7 day−1 kbp−1). (A) Summary of the accumulation pattern of defective 
mitochondria obtained by following the fate of 1000 cells. The curves show 
the fraction of cells that contain more than 0, 20, 40 or 60% defective 
mitochondria, i.e. after 200 days roughly 60% of the cells had more then 
20% of defective organelles (marked by arrow). (B) Distribution of deletion 
sizes after 1100 days. The diagram is based on the results of 1000 simulation 
runs. For further simulation details see text.










The problem that emerged in the previous simulations is that
either the deletion size distribution (high mutation rate), or the
overall frequency of defective mtDNA (low mutation rate) is
compatible with experimental data, but not both at the same
time. What would be needed is a process that increases the
mutation rate in cells harbouring mitochondrial mutants (to
displace first generation mutants), but keeps the mutation rate
low in cells that contain only wild-type genomes. The last assump-
tion that went into the modelling of the mutation process can
achieve exactly this outcome. There it was proposed that the
presence of defective mtDNA leads to increased oxidative stress
which in turn leads to an elevated mutation rate.
However, in the previous simulations the corresponding boost
factor parameter, ‘bF’, was set to one, which disabled this process.
Figure 6 shows the effects on the deletion size histogram of


















 with a boost
factor of 100. Compared to the same simulation without boost
factor (Fig. 5B), the distribution has changed as expected. A large
fraction of small deletions has disappeared and the distribution
now resembles again that of the high mutation scenario. The frac-
tion of cells containing mitochondrial mutants is not affected by
the parameter ‘bF’ and is thus identical to that seen in Fig. 5(A).
An important feature of the accumulation of defective
mtDNAs is the clonal character found experimentally. In most
affected cells only a single mutant genotypes exists apart from
the wild-type. Table 2 shows the fraction of different genotypes
within a cell for five different time points during the simulation
displayed in Fig. 6. At the start of the simulation only one geno-
type is present, the wild-type. But as the simulation progresses,
cells with more than one genotype appear. At the end of the
simulation approx. 22% of the cells contain two genotypes
(mostly wild-type plus one mutant) and approx. 8% contain
three. In the majority of the cases with multiple genotypes, one




Aging is a complex biological process that affects all the cells,
tissues and organ systems of an organism. At the molecular level,
Fig. 5 Simulation results for a low mitochondrial mutation rate 
(3 * 10
−8 day−1 kbp−1). (A) Summary of the accumulation pattern of defective 
mitochondria obtained by following the fate of 1000 cells. The mutation rate 
is 20 times lower than in Fig. 3 and as a consequence the fraction of cells 
harbouring defective organelles is, even in old animals, quite low. 
(B) Distribution of deletion sizes after 1100 days. Although only the mutation 
rate has changed the distribution is very different from the one shown in 
Fig. 3B. This time many small deletions are present after 1100 days.
Fig. 6 Distribution of deletion sizes after 1100 days for a low mitochondrial 
mutation rate (3 * 10
−8 day−1 kbp−1) and with boost factor = 100. In this 
simulation it is assumed that the presence of defective mitochondria leads 
to increased oxidative stress and an increased mutation rate. This mechanism 
leads to the disappearance of the small deletions seen in Fig. 5B.
Table 2 Distribution of the number of different mutants per cell for 5 
different time points calculated from 1000 different simulation runs. Initially 
the only existing genotype is the wild-type, but with time mutant mtDNA 
molecules are appearing
 
Time (days) 1 genotype 2 genotypes 3 genotypes 4 genotypes
0 1 0 0 0
281 0.76 0.169 0.051 0.015
563 0.65 0.186 0.074 0.038
845 0.595 0.182 0.091 0.051
1127 0.565 0.224 0.082 0.054








diverse mechanisms seem to operate, ranging from telomere
shortening, protein aggregation and oxidation to nonenzymatic
glycosylation, cross-linking and the accumulation of defective
mitochondria. Evolutionary theory strongly suggests that aging is
caused by multiple sources of damage accumulation, operating
in parallel (Kirkwood & Franceschi, 1992). Under such conditions
it is important to understand the network of reactions that
contribute to the aging phenotype. However, the initiation of such
a systems biological approach has to include an understanding
of the individual network components.
Damage to mitochondria with all its consequences is an
important part of the overall picture, but the biochemical
mechanisms that allow a mutant mitochondrion to supersede
wild-type organelles and take over the cellular population of
mitochondria are currently still unclear. It turns out to be of crucial
importance for our proposition that mitochondria undergo




. The SOS hypothesis (de
Grey, 1997) can only work if the level of fusions is very low or
nonexistent, while the idea that smaller mtDNA molecules
(deletion mutants) have a replication advantage is only realistic
when fusions occur. Previously we studied a situation where
mitochondria do not undergo fusions (Kowald & Kirkwood,
1999; Kowald & Kirkwood, 2000) as representing one extreme
in the possible range of fusion events. The jury is still out as to
whether fusions occur under physiological conditions in post-
mitotic cell types like neurons and skeletal muscle, but mounting
evidence justifies a closer inspection of the selection consequences
for small mtDNA deletion molecules. We therefore decided in this
study to look at the other end of possible fusion rates, namely
the case where mitochondria fuse and separate so frequently
that they effectively form a single mitochondrial compartment.
We modelled the mitochondrial mutation, replication and
degradation process stochastically and asked under which
conditions it is possible to reproduce important experimental
findings, such as the time course of the fraction of cells containing
mitochondrial mutants and the size distribution of mtDNA
deletions. The stochastic approach is important to account for
the probabilistic nature of mutations, which is likely to be
responsible for the mosaic pattern of healthy and impaired cells
seen in cross sections of tissues from old organisms. In some
of the simulation runs, no mitochondrial mutants were present
after 38 months, while in others a deletion event took place and
the wild-type mtDNA was replaced by the mutant. A model
composed of differential equations could not have captured such
a pattern, since this approach corresponds to the experimental
method of using tissue samples containing millions of cells. The
result is in both cases an averaging effect, obscuring the true
pattern of accumulation of mtDNA deletion mutants.
The results of the simulations show that it is possible to
reproduce the experimental findings by considering only the
three processes of mutation, replication and degradation. The
model shows that the experimentally observed paucity of small
deletions can be explained by the competition between small
deletion mutants and mutants with larger deletions that occur
less frequently but have a stronger selection advantage. However,
to fulfil at the same time both constraints – correct deletion size
distribution and low total fraction of cells with defective mtDNA
– it is necessary to assume that the presence of deletion mutants
increases oxidative stress and concomitantly the mutation rate
(the so-called boost factor).
In the simulations a boost factor of 100 was used to adjust
the shape of the deletion size histogram (Fig. 6) in the presence
of a low overall mutation rate (Fig. 5A). Is such a high boost
factor realistic? To our knowledge no experimental data exist
regarding mitochondrial mutation rates under different levels
of mtDNA mutants. However, a difference of two orders of
magnitude for cells with zero vs. 100% mutated mtDNA doesn’t
seem unreasonable. Furthermore, a factor of 100 might be an
overestimation, because the current model does not include
apoptosis. If cells harbouring a high content of mtDNA mutants
undergo frequent apoptosis, the frequency of cells with impaired
mitochondria that is actually observed in cross sections of tissues
will be much lower than the total number of affected cells that
have appeared since birth. Thus apoptosis leads to an under-
estimation of the real mitochondrial mutation rate. But if the
mutation rate is actually higher than assumed in Fig. 5, the boost
factor needed to remove small deletions can be substantially
lower than the value used in the current simulations.
At the end of the simulation shown in Fig. 6 78% of the
cells contained either one or two genotypes while 8% har-
boured three different genotypes (Table 2). Most of the two
genotype simulations represent a combination of wild-type and
mutant, but in case where three genotypes coexist in a cell at
least two different mutant mtDNAs are seen, a situation rarely
observed experimentally. Closer inspection revealed that in
those cases the frequency of one genotype often dominated
over the others. Most likely this reflects a situation where a fresh
mutation occurred very recently and is either about to overtake
the dominant genotype or will itself disappear again. The fraction
of cells with multiple genotypes observed in the simulations
depends directly on the time that a new mutant needs to replace
the existing genotype, which in turn depends on the boost
factor used. By using a higher factor the frequency of small
deletions would be even lower than in Fig. 6, while at the same
time there would be less cells with multiple genotypes. This
might indicate that a boost factor of even 100 may be too low.





., 2001), there has recently been a similar study




., 2004). Among the similar
observations, such as clonal expansion of a single mutant, a
mosaic pattern of affected cells and high incidence of large
deletions, there are also important differences. Two-thirds of
the deletions had direct repeat sequences at their breakpoints
and in one-third of the cases the light strand origin was deleted.
It is not clear how the deletion mutants without a light strand
origin could accumulate, but possibly they can make use of
alternative origins or mtDNA replication might under certain




., 2003). However, the differences of the deletion process
between rodents and primates means that different models








may be required for the two species. Since the mechanisms
operating in primates are more complex (alternative origins,
influence of repeats) and less well understood, our model aims
to reproduce the experimental observations found in rats. But
nevertheless we think that the results are relevant for primates,
since in both species the major problem is to explain the
problematic lack of small deletions.
Another interesting observation is that no deletions have














 remain intact and therefore such mutants should accumulate.
However, among the 30 deletion mutants investigated, none
had a deletion within this area. A possible explanation coming
from the present modelling study is the realization that because
of the unidirectional mode of replication the sequences within
the major arc count twice for the calculation of the replication
time. A 6 kbp deletion within the minor arc (approximately the
complete arc) is equivalent to a three kbp deletion within the
major arc. Thus, although we did not explicitly model minor arc
deletions within this study, we can predict that those deletions






The simulation results and the idea that small mtDNA
molecules have a replication advantage is also in agreement
with experimental studies which demonstrate that mtDNA with
large deletions repopulates human cells faster than wild-type
mtDNA (Moraes et al., 1999; Diaz et al., 2002). Surprisingly, a
similar replication advantage has been observed for mtDNA
point mutations that cause the MELAS encephalomyopathy in
humans (Yoneda et al., 1992). The replication advantage of these
mutants cannot be explained by a reduced length of the mtDNA.
Maybe, the changed sequence is able to attract molecular
factors necessary to replicate more efficiently than the wild-
type. This could also explain why Taylor et al. (2003) found an
accumulation of point mutations in human gut crypt cells.
Interestingly, the model has very few free parameters (see
Table 1). The degradation rate and the parameters ‘k’ and ‘c’
which control the steady state level of organelles are constrained
by experiment or have no qualitative impact on the simulation
results. This effectively only leaves the mutation rate and the
boost factor to account for the good agreement of simulation
and experimental results.
Finally, the simulations also allow us to make two predictions
that can be tested experimentally. According to the model, the
mechanism which explains the lack of small deletions is the
sequential replacement of mtDNA mutants with small deletions
by mutants with large deletions. This process takes place over
the lifespan of the rat (Fig. 4). Consequently, one prediction is
that the deletion size distribution found in young animals should
have a much larger fraction of small deletions. If it is possible
to collect enough cells with defective mitochondria in young
rats, this could be verified. The second prediction follows a similar
line as regards deletions in the small arc. In old animals these
deletions are not present because, in relation to the selection
advantage they confer, they are equivalent to deletions in the
large arc that are smaller than 3 kbp. In young animals, however,
small arc deletions should be observable, occuring at the same
frequency as large arc deletions of half the size. These predictions
are, however, only valid if the removal of impaired cells by
apoptosis is negligible.
In summary, we show that the existence or nonexistence of
mitochondrial fusions is of crucial importance for explanations of
how mutant mtDNAs can accumulate in cells. If there is fusion,
survival of the tiny (SOT) is a feasible option to explain the accu-
mulation of mitochondrial deletion mutants and gives simulation
results that are in good agreement with experimental data.
Experimental procedures
Model description
The aim of the modelling exercise was to see if two major experi-
mental findings can be reproduced by a model that assumes a
replication advantage based on the reduced size of mtDNA
deletion mutants. Firstly, it should reproduce the observation
that even in aged organisms only a minority of cells harbours
defective mitochondrial genomes, but, for that minority, the
defective genome predominates. This mosaic pattern of damage
distribution within tissues has been described by several authors
(Khrapko et al., 1999; Cao et al., 2001; Gokey et al., 2004).
Secondly, and most importantly, the model should be able to
reproduce and explain the distribution of deletion sizes found by
Cao et al. (2001) in old rats (Fig. 1). Using laser-capture micro-
dissection the authors isolated 30 respiration deficient muscle fibres
from 38 month old rats and obtained the exact size and position
of the accompanying mtDNA deletions via PCR. All deletions were
located within the major arc (see Fig. 2B) and Fig. 1 shows that
the size distribution that completely lacks deletions that are
smaller than 4 kbp and has only few deletions greater than 9 kbp.
We wanted to include only the most essential reactions in
the model and therefore incorporated mutation, replication and
degradation of mtDNA molecules.
Mutation
In this simulation study only deletion mutations affecting the large
arc (Fig. 2B) of the rat genome are considered. It is assumed
that deletions which include the heavy or light strand origin of
replication (OH and OL) are no longer capable of replication and
thus cannot accumulate. Deletions affecting exclusively the minor
arc are also excluded, since they have not been observed (Cao
et al., 2001) (see Discussion).
To further simplify and speed up the simulation, deletions are
modelled with a granularity of 100 bp, i.e. deletions can be of
100, 200 or 300 bp, but not 250 bp. Consequently, the model
contains 100 possible classes of mitochondrial genotypes,
wild-type (M0) and 99 different types of deletions ranging from
100 bp (M1) to 9900 bp (M99). Note that the name indicates
the size of the deletion. Other assumptions that have been
made regarding mitochondrial mutations are:
Accumulation of defective mitochondria with age, A. Kowald et al.
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1. Deletion mutants can suffer from further deletion events
(Mx→My, x < y). Figure 2 A shows the resulting network of
possible mutation reactions for five different types of mitochon-
dria. However, since 100 different types were used in the
simulations, the total number of mutation reactions is 4950.
2. Since no details are known of the biochemical mechanisms
underlying the deletions, we assume that the mutation rate is
proportional to the length of the mtDNA molecule and has the
dimension per day per kbp. Thus larger mtDNAs have a higher
probability of mutation than small mtDNAs.
3. Another important point is the outcome of a deletion event.
What is the size distribution of the resulting deletion mutants?
Without knowing the biochemical basis of the deletion process
it is not possible to predict if all deletions will be of identical size or
what type of distribution to expect. Under these circumstances we
assume that the deletion is the result of two random cuts within
the large arc. This leads to a distribution with a linearly increasing
probability for the occurrence of small deletions. Basically, large
deletions are very rare since only a few cut positions exist
within the large arc that will result in a large deletion fragment.
4. Finally, we investigate the possibility that the presence of
defective mtDNAs increases oxidative stress, and thus the
mutation rate, within a cell. It is therefore assumed that the
mutation rate is increased by a certain factor (the ‘boost factor’)
if 100% of the mitochondrial population is defective. A linear
relationship between the fraction of defective organelles and
the increase in oxidative stress is assumed, so that a cell with X%
mutants has its mutation rate increased by a boost factor * X/100.
Taking the above points into account the following equation
can be constructed that calculates the mutation rates leading
from one mutant type to another. The first term describes the
effects of increasing oxidative stress caused by mitochondrial
mutants (point 4). If there are only wild-type organelles (M0),
the term reduces to one, leaving the mutation rate unchanged,
as calculated by the second term. But for a population consisting
to 100% of mutants (M1 to M99) the first term evaluates to bF,
the boost factor.
The second term incorporates the assumption that the
mutation rate is per kbp and therefore the baseRate is multiplied
by the length of the mtDNA of mutant Mi, which is given by
(16 – 0.1 * i). Furthermore, we have to take into account that
small deletions are more likely to occur than large ones (point 3).
There is a 1/1002 chance of placing two random cuts (limited
to 100 bp intervals) such that a 10 kbp piece results, but there
is a 100/1002 chance of placing the two cuts such that a 0.1 kbp
piece results (i.e. a (100 − k)/10 000 chance for a deletion size
of k * 0.1 kbp). Since the total mutation rate is distributed
among all possible resulting mutants ,
the resulting equation is given by:
Replication
It is assumed that replication time is proportional to the length
of the mtDNA molecule. However, because of the special mode
of replication of mtDNA, some regions of the mitochondrial
genome count twice. The origins of replication of the heavy and
light strands of the mammalian mtDNA molecule (OH and OL,
respectively) are located at different positions on the molecule
(Fig. 2B). The replication process proceeds asymmetrically via
strand-displacement (Tapper & Clayton, 1981; Clayton, 2003).
Leading strand synthesis starts at OH and continues clockwise
along the major arc until it reaches and exposes the origin of
the lagging strand, OL. Only now can lagging strand synthesis
start counter-clockwise through the major arc, while leading
strand synthesis continues through the minor arc until it has
completed a full round of replication. However, the process is
not finished until lagging strand synthesis has also completed
the full circle of DNA.
The time for the total replication process is therefore the time
required for the synthesis of the full length molecule plus the
time that the start of light strand synthesis lags behind the start
of heavy strand synthesis. For the wild-type molecule this is the
time required to synthesize 16 kbp +10 kbp = 26 kbp so that
the major arc effectively counts twice. As a consequence a
mutant with a complete deletion of the major arc replicates
26/6 = 4.33 times faster than wild-type and not 16/6 = 2.66
times, as might have been expected.
To construct a model that leads to a steady state population
of mtDNA molecules we have to add negative feed back such
that the total synthesis of mtDNA declines with increasing copy
number in the cell. The following equation shows how this feed
back enters into the calculation of the replication rate for
mutant Mi. The first term is a Hill type product inhibition
depending on the total number of genomes, a parameter which
controls when the total synthesis rate has reached 50% of its
maximum (k). The latter is an exponent determining how sharply
the system reacts if the number of mtDNA departs from ‘k’.
The term includes a constant specifying the maximum number
of mtDNA that can be produced per day (c).
If there are no mtDNA molecules, the total number of newly
synthesized genomes is ‘c’, if the number of mtDNAs is equal
to ‘k’ the synthesis rate is reduced to ‘c/2’ and if the number
of mtDNAs is very large the total synthesis rate approaches zero.
We also have to specify how the total amount of synthesized
mtDNAs is distributed between the different types (mutants).
This is done by the second term that basically weights the
different types according to their size advantage and number.
If there is only wild-type (M0), the second term simplifies to 1,
indicating that all synthesized genomes will be wild-type. If
there is a mutant with a 10 kbp deletion (M100) together with
i
i















(   )  
    







































    .
  




















Accumulation of defective mitochondria with age, A. Kowald et al.
© Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2005
281
equal amounts of wild-type, a fraction 1/(1 + 26/6) = 0.1825 of
the newly synthesized genomes will be wild-type and a fraction
(26/6)/(1 + 26/6) = 0.8125 will be of type M100.
Degradation
If new mtDNAs are synthesized some genomes have to be
degraded to maintain a stable population size. Unfortunately,
little is known about the process of mitochondrial degradation.
It is not known if they are selected for degradation according
to the amount of membrane damage, as suggested by the SOS
hypothesis (de Grey, 1997) or if they are selected randomly.
However, here we are exclusively interested in the effects of
different mtDNA sizes and in this context degradation of
mitochondria means degradation of mtDNA molecules. For the
purpose of this study we assume identical degradation rates,
and therefore half-lifes, for all types of mtDNAs (M0 to M99).
For all simulations shown, the half-life was set to 10 days (see
also Table 1).
Implementation
The model outlined above was simulated stochastically to
explicitly take into account random fluctuations and the discrete
nature of the studied biological objects. Mutation events with
their inherently small probabilities require a nondeterministic
approach to describe adequately the finding that in old animals
some cells do contain mitochondrial mutants and others do not.
Gillespie developed exact stochastic simulation algorithms that
directly calculate the change of the number of molecules of
the participating species during the time course of a chemical
reaction (Gillespie, 1977). Thus stochastic algorithms calculate
explicitly the time until the next reaction takes place (e.g.
A→B + C) and keep track of how the number of molecules in
the system is changed by this reaction (A decreased by one, B
and C increased by one). Such an approach also deals with the
discrete nature of molecule numbers. This is of special importance
for self-replicating entities (like mtDNAs) if the number of objects
is either zero or one. One mutant mtDNA can multiply and take
over the cell, while zero mtDNA molecules obviously cannot.
Differential equations, however, assume that variables can attain
continuous values, so that 0.001 mtDNAs is a valid simulation
result. Because this value is different from zero it is theoretically
possible that a population of mutants can recover from such
low levels and replace the wild-type: an unrealistic situation
which is avoided by stochastic simulations.
The free software package Dizzy was used for all simulations
(Ramsey & Orrell, 2005). Dizzy is written in Java and implements
several stochastic (Gillespie, Gibson-Bruck, Tau-Leap) and
deterministic (ODE solvers) simulation algorithms. Models can be
described in Systems Biology Markup Language (SBML) (Hucka
et al., 2003) or using a proprietary model definition language
(CMDL). Because of a special language construct it was possible
to define the 4950 mutation reactions with just five lines of code
in CMDL. To be comparable with the experimental conditions
of Cao et al. (2001), Gillespie’s direct method was used to
calculate the fate of a mitochondrial population within a cell
for 1100 days, corresponding to 38 months of a rat’s life. On
a modern workstation such a calculation took approx. 1 h. The
simulation was then repeated 1000 times on a Linux cluster
to have enough information for a statistical analysis of the
accumulation process of defective mitochondria.
The CMDL script that was used for simulations as well as
a Python program used for the analysis of the Dizzy output is
available as supplementary material.
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